CMS, Industry Debate Role Of Physician Guidelines In Coverage Decisions
This article was originally published in The Pink Sheet Daily
Executive Summary
Professional society guidelines alone do not justify reimbursement coverage, CMS, AHRQ officials assert at AdvaMed reimbursement policy conference. Guidant exec says CMS’ reluctance to accept the guidelines is a “potent concern.”
You may also be interested in...
CMS’ Barry Straube Chats About Coverage-With-Evidence Development
Straube vows that CMS' coverage-with-evidence development policy will not be used to restrict coverage for new technologies.
Allergan Bid For Device Firm Inamed Would Diversify Aesthetic Offerings
Purchase of Inamed would give Allergan entry into the facial aesthetics market and augment Allergan's Botox franchise. The $3.2 bil. offer for Inamed marks a $450 mil. premium over fellow bidder Medicis.
Digene Aims To Capitalize On Planned HPV Vaccine Launch In 2006
The firm is discussing partnerships with Merck, GSK to co-promote use of its HPV test with forthcoming human papillomavirus vaccines.